SCHEMBL29598147

SCHEMBL29598147

O=Cc1cncc(-c2ccc(F)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIP4K2B P78356 1/20 0.51
CYP11B1 P15538 3/20 0.45
CYP11B2 P19099 2/20 0.45
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SCN10A Q9Y5Y9 1/20 0.41
CHRNB4 P30926 2/20 0.41
CHRNA3 P32297 2/20 0.41
PTGS2 P35354 2/20 0.40
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
ALDH1A1 P00352 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PTGS1 P23219 1/20 0.39
HDAC1 Q13547 1/20 0.38
PIK3C3 Q8NEB9 1/20 0.38
KIF11 P52732 1/20 0.38
CYP17A1 P05093 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1582492 1.00 PIP4K2B (0.51) PIP4K2BCYP11B1CYP11B2KDM4EMEN1
SCHEMBL31180051 0.84 PTGS2 (0.38) PIP4K2BPTGS2ALDH1A1HDAC1
SCHEMBL1356430 0.84 PTGS2 (0.38) PIP4K2BPTGS2ALDH1A1HDAC1
SCHEMBL2558411 0.81 CYP3A4 (0.41) PIP4K2BCYP11B1CYP11B2KDM4EMEN1
SCHEMBL2321467 0.81 HDAC1 (0.55) PIP4K2BKDM4EMEN1KMT2ACHRNB4
SCHEMBL13621779 0.81 PTGS2 (0.54) PIP4K2BCYP11B1CYP11B2SCN10ACHRNB4
SCHEMBL30345862 0.81 MKNK1 (0.47) CYP11B1CYP11B2KDM4EMEN1KMT2A
SCHEMBL2106457 0.81 MKNK1 (0.47) CYP11B1CYP11B2KDM4EMEN1KMT2A
SCHEMBL29066290 0.81 PIP4K2B (0.54) PIP4K2BCYP11B1CYP11B2KDM4ECHRNB4
SCHEMBL28129428 0.81 PTGS2 (0.38) PIP4K2BPTGS2HDAC1KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115304591-B Bridged ring steroid synthetase inhibitor and preparation method and application thereof 广州中医药大学(广州中医药研究院) 2024-10-01 CN disclosed
EP-4255902-A1 2,3-DIHYDRO-4H-BENZO[B][1,4]OXAZIN-4-YL)(5-(PHENYL)-PYRIDIN-3-YL)METHANONE DERIVATIVES AND SIMILAR COMPOUNDS AS CYP11A1 INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER Orion Corporation (FI) 2023-10-11 EP disclosed
CN-115304591-A Bridged steroid synthetase inhibitor and preparation method and application thereof 广州中医药大学(广州中医药研究院) 2022-11-08 CN disclosed
WO-2022117920-A1 2,3-DIHYDRO-4H-BENZO[B][1,4]OXAZIN-4-YL)(5-(PHENYL)-PYRIDIN-3-YL)METHANONE DERIVATIVES AND SIMILAR COMPOUNDS AS CYP11A1 INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER ORION CORPORATION (FI) 2022-06-09 WO disclosed